• Home
• Medicine ↘
  • Medical Uses
  • Side Effects ↘
  • Studies and Case Reports
• Science ↘
  • Definitions
  • List of Clinical Studies
  • Database of Clinical Studies
  • Clinical Studies 2005-2009
  • Clinical Studies 2010-2014
• Laws and Politics ↘
  • Overview English
  • Austria/Österreich
  • Belgium
  • Canada
  • Chile
  • Croatia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany / Deutschland
  • Israel
  • Italy / Italia
  • Japan
  • Luxembourg
  • New Zealand
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • The Netherlands / Nederland
  • UK
  • United States of America
• Partners worldwide ↘
  • Partner organisations
• Archive ↘
  • IACM-Bulletin
• FAQ
• British Association ↘
  • Legal Status
  • Sativex
  • Cannabinoids
• Links
• About us ↘
  • Introduction
  • Board of Directors
  • Statutes
• Membership
• Donation
• Imprint
• Data Protection Regulation

• Newsletter
  • IACM-Bulletin
  • Subscribe
• Journal
  • CCR (current)
  • Cannabinoids (former)
  • Therapeutics (former)
• Conference & Webinars
  • Webinars & Anniversary Online Meeting (both free)
  • Former
  • ICRS
• Language
  • English
  • Deutsch
  • Français
  • Nederlands
  • Español
  • Português
  • Italiano

Current IACM-Bulletins

The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe online.

---

Full Text Search (Extended...)
AND connection of search terms OR connection of search terms Professional search (Help...)	Observe small/capital letters Do not observe small/capital letters

• IACM-Bulletin of 08 May 2022
• IACM: Cannabinoid Conference 2022
• Science/Human: Cannabis improves sleep in patients suffering from depression or anxiety
• Science/Human: A selective agonist to the CB2 receptor improved symptoms indermatomyositis in clinical trial

• IACM-Bulletin of 24 April 2022
• Science/Human: Cannabis may be helpful in inflammatory bowel disease according to survey
• Science/Human: The legalisation of cannabis for adults may be associated with reduced prescription drug use
• Science/Human: A cannabis extract was superior to long acting opiates in patients with neuropathic back pain

• IACM-Bulletin of 10 April 2022
• IACM: The Cannabinoid Conference 2022 is dedicated to Daniela Parolaro
• IACM: Former Chairwoman Daniela Parolaro passed away
• USA: House of Representatives supports the legalisation of cannabis, but the bill faces dim prospects in the Senate
• Science/Human: THC reduces opioid use in older pain patients even in low doses
• Science/Human: The legalisation of cannabis in the USA did not increase cannabis-related treatments
• Science/Human: Cannabidivarin may be effective in the treatment of epilepsy in girls with Rett syndrome

• IACM-Bulletin of 27 March 2022
• Science/Human: Cannabis may be helpful in Tourette syndrome according to an open study
• Science/Human: The anxiolytic effect of CBD depends on the nature of trauma in post-traumatic stress disorder
• Science/Human: Cannabis is effective in the treatment of nausea according to self-reports
• Science/Human: Cannabis use is common in patients with hair loss and helps them cope with anxiety and depression

• IACM-Bulletin of 13 March 2022
• Costa Rica: The medical use of cannabis is now legal
• Science/Human: Three further studies confirm the evidence, that cannabis use by pain patients may reduce the need for opioids

• IACM-Bulletin of 27 February 2022
• Science/Human: Cannabis treatment is associated with improved quality of life according to a large study
• Science/Human: The combination of melatonin and CBD may treat insomnia

• IACM-Bulletin of 13 February 2022
• USA: Mississippi becomes the 37th state to legalise the medical use of cannabis
• Science/Human: Cannabis may be helpful in the treatment of chronic migraine according to a retrospective study
• Science/Human: A cannabis extract and pure THC reduce pain according to two analyses from the German Pain e-Registry
• Science/Human: Patients with neuropathic pain may benefit from a treatment with cannabis
• Science/Human: Cannabis use is associated with decreased mortality in trauma patients

• IACM-Bulletin of 30 January 2022
• Science: Basic research on cannabinoids in COVID 19 should be interpreted with caution
• Science/Human: Topical treatment with cannabis eye drops may be effective in blepharospasm
• Science/Human: Cannabis smoking has different effects on lung function than tobacco

• IACM-Bulletin of 16 January 2022
• Science/Cells: Cannabinoids may have the potential to prevent and treat infection by the new coronavirus
• Science/Human: Among older adults in Canada medicinal cannabis products are more often used by women than by men
• Science/Human: Cannabis is used for a variety of medical reasons in the USA and Canada
• Science/Human: Fatal outcome in a clinical study with the new FAAH inhibitor in healthy adults

• IACM-Bulletin of 02 January 2022
• Science/Human: The medical use of cannabis may be helpful in severe treatment resistant epilepsy
• Science/Human: CBD in addition to THC in cannabis cigarettes reduces anxiety while keeping positive subjective effects
• Science/Animal: CBD inhibits growth of glioblastoma by altering the tumour microenvironment among other mechanisms